Iterum Therapeutics (ITRM) Short term Debt (2018 - 2022)
Historic Short term Debt for Iterum Therapeutics (ITRM) over the last 5 years, with Q3 2022 value amounting to $610000.0.
- Iterum Therapeutics' Short term Debt fell 9335.73% to $610000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $610000.0, marking a year-over-year decrease of 9335.73%. This contributed to the annual value of $6.1 million for FY2021, which is 7901.26% down from last year.
- Per Iterum Therapeutics' latest filing, its Short term Debt stood at $610000.0 for Q3 2022, which was down 9335.73% from $1.6 million recorded in Q2 2022.
- Over the past 5 years, Iterum Therapeutics' Short term Debt peaked at $28.9 million during Q1 2021, and registered a low of $610000.0 during Q3 2022.
- Over the past 5 years, Iterum Therapeutics' median Short term Debt value was $5.9 million (recorded in 2019), while the average stood at $12.2 million.
- In the last 5 years, Iterum Therapeutics' Short term Debt soared by 113341.44% in 2020 and then plummeted by 9335.73% in 2022.
- Quarter analysis of 5 years shows Iterum Therapeutics' Short term Debt stood at $1.0 million in 2018, then skyrocketed by 469.19% to $5.8 million in 2019, then soared by 397.67% to $28.9 million in 2020, then crashed by 79.01% to $6.1 million in 2021, then crashed by 89.93% to $610000.0 in 2022.
- Its last three reported values are $610000.0 in Q3 2022, $1.6 million for Q2 2022, and $4.5 million during Q1 2022.